Clovis Oncology, Inc. Gains 30.43%
Mon, Sep 12, 2022 at 07:39 PM
Clovis Oncology, Inc. (CLVS:NASDAQ) soared at $1.5, representing a gain of 30.4%. On Mon, Sep 12, 2022, CLVS:NASDAQ touched a New 2-Week High of $1.5. The stock got featured on our News Catalysts scanner on Mon, Sep 12, 2022 at 12:32 PM in the 'BIOTECH' category. From Mon, Aug 29, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Fri, Jul 08, 2022 at $3.25 with a volume of 104M+.
About Clovis Oncology, Inc. (CLVS:NASDAQ)
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Top 10 Gainers:
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 101.3%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 70.42%
- Ventyx Biosciences Inc. (VTYX:NASDAQ), 64.98%
- PolyPid Ltd. (PYPD:NASDAQ), 58.33%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 38.1%
- PaxMedica Inc. (PXMD:NASDAQ), 36.59%
- IDEAYA Biosciences, Inc. (IDYA:NASDAQ), 30.7%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 30.43%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 27.68%
- IHS Holding Limited (IHS:NYSE), 24.88%